Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Palmetto Issues Final LCD for DermTech Pigmented Lesion Assay

Palmetto Issues Final LCD for DermTech Pigmented Lesion Assay

Jan 02, 2020
|
staff reporter

NEW YORK – Dermatology genomics testing company DermTech said on Thursday that Medicare Administrative Contractor Palmetto GBA MolDx has issued a final local coverage determination for the company's Pigmented Lesion Assay (PLA).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Even Bigger

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Got Into the Lab Machines

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Not Going to Pay

Science reports that a Dutch research funding agency is combating a ransomware attack.

Science Papers Present Haplotype-Resolved Genomes, MiRNA-Linked Complex Tied to Ribosomal Protein Production

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.

What's Popular?

In Business News

  1. Luminex Shares Surge on Rumor of Acquisition by DiaSorin

  2. GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales

  3. People in the News: New Appointments at Qiagen, ImmunoScape, 908 Devices, More

  4. Natera Revenues Grow 35 Percent in Q4

  5. Genomics Firms Taking Advantage of SPACs Trend to Go Public Faster

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.